TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01205269

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD8683, 50 mcg
Description: Dry powder for inhalation, single dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD8683, 50 mcg
Description: Dry powder for inhalation, single dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD8683, 50 mcg
Description: Dry powder for inhalation, single dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD8683, 50 mcg
Description: Dry powder for inhalation, single dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD8683, 50 mcg
Description: Dry powder for inhalation, single dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD8683, 50 mcg
Description: Dry powder for inhalation, single dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Dry powder for inhalation, single dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Dry powder for inhalation, single dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Dry powder for inhalation, single dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Dry powder for inhalation, single dose
Study: NCT02919579

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo (Oral)
Description: Participants will receive oral placebo in Part A (as per the treatment sequence in period 1,2 and 3).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo (Oral)
Description: Participants will receive oral placebo in Part A (as per the treatment sequence in period 1,2 and 3).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo (Oral)
Description: Participants will receive oral placebo in Part A (as per the treatment sequence in period 1,2 and 3).
Study: NCT02391402

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitively Augmented Behavioral Activation
Description: CABA uses Behavioral Activation (BA) to identify meaningful goals and activities while learning cognitive skills to aid in working toward those goals. Early sessions of CABA focus on learning about mTBI, PTSD, and lifestyle skills that can improve thinking abilities and mood. Cognitive skills taught each week include internal and external skills to help manage problems with memory, attention, and regulation of thinking processes. Investigators and patients will spend a part of each session applying the cognitive skills to managing real life situations and getting patients active in the service of personal goals.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Treatment as Usual
Description: TAU care involves psychotherapy (counseling) provided by a specialist in the treatment of PTSD. Patients will be offered individual appointments with an experienced provider on the PTSD Clinical Team (PCT). Beyond this, the specific approach will be determined by the patient and his/her provider and may include skills for managing PTSD and/or a chance for the patient to process his/her traumatic experiences. Additional treatments may be offered to patients, such as group classes and medications. TAU care may also include additional evaluation and/or treatment of mTBI, provided by the usual care offered in Portland or Seattle's respective neuropsychology clinics. Treatment for mTBI includes individual or group sessions, and is based on clinical need.
Study: NCT04035941

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cycle Nation Multicomponent Intervention
Description: This intervention group will receive 4 elements:~1. Practical skills programme: a workplace-based programme covering basic cycling skills, delivered by trained 'cycle champions' - HSBC staff members.~2. Cycle provision scheme: participants will have the opportunity to have their own bicycles serviced or obtain a loaned bike or e-bike from local bike shops before the start of the programme.~3. Cycle-friendly workplace culture: all offices taking part will have a minimum of secure bike parking facilities as part of an ongoing roll-out of cycle infrastructure across HSBC UK offices.~4. Our Cycle Hub app: an adapted version of an existing HSBC app including route planning, goal setting and practical skills videos, as well as supportive social interaction among participants.
Study: NCT02330835

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: In the Drivers Seat
Description: Multimedia student behavior management program for school bus drivers and school administrators

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: School bus driver training videos
Description: Basic bus driving safety videos
Study: NCT03434717

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Individualised rehabilitation
Description: Patients will get access/support to individualised rehabilitation based on their needs identified through the distress thermometer

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Care as usual
Description: Patients will get care as usual

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Care as usual
Description: Patients will get care as usual
Study: NCT05809518

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol injection
Description: sedation after cardiac surgery

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine injection
Description: sedation after cardiac surgery

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine and Propofol
Description: sedation after cardiac surgery
Study: NCT01496651

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Percutaneous coronary intervention
Description: PCI will be performed by the femoral or the transradial approach. In complex distal lesion anatomies, the use of 7-8F guiding catheters and the transfemoral approach may be recommended. Ostial and mid-shaft lesions will be treated with a single stent. For the treatment of distal bifurcation lesions crush, culotte, T-stenting, V-stenting or a single stent strategy may be used according the lesion morphology and the experience of the operator. However, based on the Nordic Bifurcation Studies the culotte technique seems to be associated with especially favorable angiographic and long-term clinical results in these large vessel size bifurcation lesions.~There should be a low threshold for the use of high pressure post dilatation balloons. Generally, final kissing balloon dilatations are encouraged and mandatory when two-stent techniques are used. Intravascular ultrasound (IVUS) in mandatory pre and post stent placement.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Coronary artery bypass graft operation
Description: Patients randomized to the CABG group for the treatment of LMCA stenosis are treated according to current clinical practice. Both off-pump and on-pump techniques can be used and the selection between the used methods is operator dependent. The left internal mammary artery will be used for the revascularization of the left anterior descending coronary artery, whenever feasible. For other lesion location, saphenous venous grafts, free arterial grafts or the right internal mammary artery may be used.
Study: NCT04362358

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online cognitive behavioral therapy (CBT)
Description: 7 sessions of Cognitive Behavioural Therapy (CBT) online + possibility to contact the psychological hotline

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Online bibliotherapy programme
Description: online bibliotherapy programme on the Ma Santé website Also with explanatory sheets and tools to improve stress management and the possibility of contacting the Psychological Hotline
Study: NCT00969891

Intervention type: OTHER
Intervention: PK-PD analysis
Description: The danish medicines agency regards new knowledge in pharmacokinetics and pharmacodynamics as an intervention.
Study: NCT01449305

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nanoone Woman Underwear
Description: Chen Yi Enterprise, Co., Ltd. design a kind of negative ion materials can supply delocalized electron, and add fiber inside, make clothes to wear in the body, no external power or battery, only depend on infrared body photon hit of thermoelectric effect or heart compression pulse, blood flow of piezoelectric, therefore can sustained sufficient amount of effective negative ion, to eliminate positive ions in vivo, or make oxygen free radical to obtain the lack electrons. Decrease active free radical and get non toxic effect in short time.
Study: NCT00765167

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Fluoride
Description: Brush half mouth twice daily for four days

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Triclosan
Description: Brush half mouth daily for four days

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chlorhexidine gluconate
Description: Mouth rinsing with 15 ml for 30 seconds twice a day for four days

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluoride
Description: Brush half mouth daily for four days
Study: NCT03846843

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OCR-002 IR Oral Tablet
Description: OCR-002 3 gram immediate release (IR) tablet for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OCR-002 IR Oral Tablet
Description: OCR-002 3 gram immediate release (IR) tablet for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OCR-002 IR Oral Tablet
Description: OCR-002 3 gram immediate release (IR) tablet for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OCR-002 Oral Solution
Description: OCR-002 5 gram solution for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OCR-002 Oral Solution
Description: OCR-002 5 gram solution for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OCR-002 IV Solution
Description: OCR-002 5 gram solution for intravenous (IV ) administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OCR-002 IV Solution
Description: OCR-002 5 gram solution for intravenous (IV ) administration
Study: NCT02577705

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self Empowerment Groups
Description: The Self Empowerment Groups (SEG) curriculum draws key components from the S.E.L.F. tool within Sanctuary, focusing the four domains: creating personal, emotional, moral and physical safety (S), processing and managing emotions (E), recognizing loss and letting go (L), and developing goals for a sense of future (F). S.E.L.F. establishes a common language that all people who have experienced adversity can use to organize their lives and work towards building stable foundations to support their goals and invest in their potential.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Financial Empowerment
Description: The Financial Empowerment curriculum developed for this study consisted of interactive exercises, worksheets, and journal assignments that fostered understanding and practice of banking, building credit and debt management, making the most of one's money, and setting financial goals for oneself and one's family. Content focused on identifying and harnessing the internal and external resources that participants can leverage to begin taking steps towards financial self-sufficiency.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Financial Empowerment
Description: The Financial Empowerment curriculum developed for this study consisted of interactive exercises, worksheets, and journal assignments that fostered understanding and practice of banking, building credit and debt management, making the most of one's money, and setting financial goals for oneself and one's family. Content focused on identifying and harnessing the internal and external resources that participants can leverage to begin taking steps towards financial self-sufficiency.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Matched Savings
Description: Participants were assisted with opening a savings accounts at a local non-profit federal credit union (with 1:1 matches of up to twenty dollars per month) over the course of 12 months.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Matched Savings
Description: Participants were assisted with opening a savings accounts at a local non-profit federal credit union (with 1:1 matches of up to twenty dollars per month) over the course of 12 months.
Study: NCT03892486

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The high PUFA diet group
Description: Assumptions of nutritional intervention: in a randomized manner volunteers will be assigned to one of two groups: a control group which will receive general nutritional recommendations, based on the Polish nutrition pyramid, and the intervention group which will receive nutritional recommendations, based on the Polish nutrition pyramid and will consume at least 4 tablespoons of olive oil or 30 grams of nuts every day for 12 weeks.
Study: NCT04558957

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FLEBOGRIF
Description: The catheter is a device dedicated to mechano-chemical ablation of insufficient veins of the superficial system.
Study: NCT02268526

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CSJ148
Description: CSJ148 IV q 4weeks

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CSJ148
Description: CSJ148 IV q 4weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo IV q 4weeks
Study: NCT00835068

Intervention type: OTHER
Intervention: No intervention
Description: As it is a non interventional study, patient receives his usual treatment (BeneFIX) as determined by the physician
Study: NCT00388674

Intervention type: DRUG
Intervention: entecavir
Description: Tablets / Oral Solution, Oral, ETV = 0.5 mg - 1 mg, once daily, Investigator/Patient decision

Intervention type: DRUG
Intervention: Other anti-HBV medication
Description: Tablets / Oral Solution, Oral, depends on chosen active comparator, depends on chosen active comparator, Investigator/Patient decision
Study: NCT00713713

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Mechanical ventilation with low and high tidal volume
Description: Tidal volume of 6 or 12 ml.kg-1, calculated on ideal body weight
Study: NCT03148327

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab (MEDI 4736)
Description: Early studies has shown to possibly reduce the growth of certain types of lung cancer

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab (MEDI 4736)
Description: Early studies has shown to possibly reduce the growth of certain types of lung cancer

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Description: Stereotactic Body Radiation Therapy (SABR)

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Description: Stereotactic Body Radiation Therapy (SABR)

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Radiotherapy
Description: Stereotactic Body Radiation Therapy (SABR)
Study: NCT02726672

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: respiratory rehabilitation using Powerbreathe
Description: 10 minutes 2 times a day : 30 inspirations per session during 10 weeks
Study: NCT02627885

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Internet-based CBT
Description: Through the use of CBT material at an Internet-platform, we aim for behavioral changes in the subjects to improve everyday level of functioning and quality of life.

Intervention type: OTHER
Group type: OTHER
Intervention: SMT
Description: Standard Medical Treatment includes pharmacological management and other typical medical interventions for the patient group but no behavioural interventions
Study: NCT03966196

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Measurements of oxygen saturation and finger pressure during deep inspiration
Description: Measurements during deep inspiration of oxygen saturation with pulse oximeter and finger pressure with pressure cuff

Intervention type: OTHER
Group type: OTHER
Intervention: Measurements of oxygen saturation and finger pressure during deep inspiration
Description: Measurements during deep inspiration of oxygen saturation with pulse oximeter and finger pressure with pressure cuff
Study: NCT01372527

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: TopCare: Use of provider knowledge vs. automated system
Description: We will be evaluating the system in practices where providers are involved in determining to contact a patient, including the most appropriate outreach method, compared with practices where the system is fully automated without provider input.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TopCare: Use of provider knowledge vs. automated system
Description: We will be evaluating the system in practices where providers are involved in determining to contact a patient, including the most appropriate outreach method, compared with practices where the system is fully automated without provider input.
Study: NCT01610167

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: NUPRO Classic Prophy Paste
Description: Abrasive, flavored dental prophylaxis paste for cleaning and polishing teeth.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NUPRO Sensodyne Prophy Paste with Novamin with fluoride.
Description: Abrasive, flavored dental prophylaxis paste for cleaning and polishing teeth.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NUPRO Sensodyne Prophy Paste with Novamin without fluoride.
Description: Abrasive, flavored dental prophylaxis paste for cleaning and polishing teeth.
Study: NCT00843063

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: pantoprazole vs famotidine
Description: pantoprazole 20 mg om and matching placebo nocte vs. famotidine 40 mg om and nocte

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: pantoprazole vs famotidine
Description: pantoprazole 20 mg om and matching placebo nocte vs. famotidine 40 mg om and nocte
Study: NCT01460121

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: SpotOn's corrective elements for dizziness
Description: Eyeglasses with dizziness correction elements (real SpotOn eyeglasses) or eyeglasses with placebo (sham eyeglasses) elements will be worn during the whole four weeks study period.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SpotOn's corrective elements for dizziness
Description: Eyeglasses with dizziness correction elements (real SpotOn eyeglasses) or eyeglasses with placebo (sham eyeglasses) elements will be worn during the whole four weeks study period.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT03540407

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Oncoxin-Viusid®
Description: Administration of the Oncoxin-Viusid® oral solution 25 mL three times a day during the concurrent Radiotherapy and Chemotherapy treatment and up to 3 weeks after the end of the onco-specific treatment

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administration of the Oncoxin-Viusid® oral solution placebo 25 ml three times a day during the concurrent Radiotherapy and Chemotherapy treatment and up to 3 weeks after the end of the onco-specific treatment
Study: NCT00769431

Intervention type: OTHER
Group type: NO_INTERVENTION
Intervention: educational intervention

Intervention type: OTHER
Group type: NO_INTERVENTION
Intervention: study of socioeconomic and demographic variables
Study: NCT00437437

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brivanib
Description: Tablet, Oral, Brivanib 800 mg, QD after single dose Pk comparison of food effect, until progression
Study: NCT00488046

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: H5N1 (6-2) AA ca Recombinant (A/Hong Kong/213/2003 x A/AnnArbor/6/60 ca)
Description: Intranasal vaccine
Study: NCT03464045

Intervention type: DRUG
Intervention: empagliflozin
Description: drug

Intervention type: DRUG
Intervention: DPP-4 inhibitors
Description: drug
Study: NCT05190081

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TASK TRAINING
Description: A special program including motor and cognitive tasks was prepared. Both lower and upper extremity motor tasks and verbal, arithmetic, auditory, and visual cognitive tasks were planned based on evidence. The dual-task and single-task training were held 2 days a week, 40 minutes, for a total of 10 sessions for 5 weeks. A patient-appropriate task was selected for each cognitive task each week.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TASK TRAINING
Description: A special program including motor and cognitive tasks was prepared. Both lower and upper extremity motor tasks and verbal, arithmetic, auditory, and visual cognitive tasks were planned based on evidence. The dual-task and single-task training were held 2 days a week, 40 minutes, for a total of 10 sessions for 5 weeks. A patient-appropriate task was selected for each cognitive task each week.
Study: NCT03952247

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Single Use Bronchoscopy for PDT
Description: optical guidance of percutaneous tracheotomy is done by single use bronchoscopy

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Multi Use Bronchoscopy for PDT
Description: optical guidance of percutaneous tracheotomy is done by conventional multi use bronchoscopy
Study: NCT04790149

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Conventional Rehabilitation
Description: Motor Imagery Training combined with Active functional exercises

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: NEUROM + tDCS
Description: NEUROM combined to tDCS

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: NEUROM
Description: protocol to induce motor recovery
Study: NCT03953911

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Mobile Clinic
Description: This intervention involves the availability of a free mobile clinic operated by Cedar-Sinai Medical Center providing free HPV vaccinations at school campuses.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Mobile Clinic
Description: This intervention involves the availability of a free mobile clinic operated by Cedar-Sinai Medical Center providing free HPV vaccinations at school campuses.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Educational Sessions for Parents
Description: This intervention involves providing free weekly educational sessions for parents of students at the participant schools pertaining to the HPV Vaccination.
Study: NCT03558789

Intervention type: BIOLOGICAL
Intervention: bovine lactoferrin
Description: mouthwash

Intervention type: BIOLOGICAL
Intervention: bovine lactoferrin
Description: mouthwash